Elicio Therapeutics, Inc.
- Est. revenue
- $5M–$10M
- Total raised
- $379M
- Latest round
- Post-IPO Equity
- Employees
- 47
Funding & revenue at Elicio Therapeutics, Inc.
How well capitalized the business is — useful context before you scope a fractional engagement or negotiate a rate.
Estimated annual revenue
$5M–$10M
Modeled range, not company-reported
Total capital raised
$379M
9 known investors
Latest round
Post-IPO Equity · $15M
Jul 2026
Publicly traded
ELTX, ELICIOTHERAPEUTICS
IPO Jun 2023
Investors
Growth signals
How fast Elicio Therapeutics, Inc. is adding people, roles, and audience.
Employees
47
Reported band 11-50
Open roles
1
0% year over year
LinkedIn followers
6.8K
+42.1% year over year
Headcount change
- MoM
- 0%
- 0 people
- QoQ
- 0%
- 0 people
- 6mo
- +2.2%
- +1 people
- YoY
- +11.9%
- +5 people
- 2yr
- +17.5%
- +7 people
Team composition
Where Elicio Therapeutics, Inc. concentrates its people — a read on which function a fractional leader would plug into.
By function
- Research1532%
- Business Development613%
- Legal49%
- Operations49%
- Accounting36%
- Information Technology36%
- Finance24%
- Human Resources24%
By region
- United States45
- Greater Boston25
- Massachusetts, United States22
- Boston, MA12
- California, United States8
- Cambridge, MA6
Inside Elicio Therapeutics, Inc.
What the business focuses on, where it operates, and how employees rate it.
Categories
Markets
Competitors
Companies in the same market as Elicio Therapeutics, Inc..
Elicio Therapeutics, Inc. in the news
Recent coverage picked up alongside the firmographic refresh.
- 5 drugmakers chasing Merck and Moderna in the cancer vaccine race
Sep 2026
- ELTX Stock Heads For Worst Day Ever — Elicio Therapeutics' Pancreatic Cancer Data Disappoints
Sep 2026
- Elicio Therapeutics Inc. (NASDAQ: ELTX) Stock Price, News & Analysis
Sep 2026
- Director at Elicio Therapeutics (NASDAQ: ELTX) receives 21,750 stock options
Sep 2026
- Director at Elicio Therapeutics (ELTX) gets 10-year stock option grant
Sep 2026
- Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference
Aug 2026
Jobs
1Funding, revenue, headcount, and hiring figures are third-party estimates from public sources and are not confirmed by the company. Last refreshed October 14, 2026.
About this page
This company page is automatically generated based on publicly available job postings. Company information is sourced from publicly available data and may not be complete. If you represent Elicio Therapeutics, Inc., you can claim this page to manage and enhance it.